Main characteristics of Mexicans with COVID-19, users of any MoH care unit, by indigenous status. Mexico, 1 March 2020 to 28 February 2021
| n (%) | Total 795 878 (100) | Non-indigenous 787 856 (98.99) | Indigenous 8022 (1.01) | P value |
| Column % or mean (95% CI) | ||||
| Individual | ||||
| Sex | ||||
| Male | 48.9 (48.8 to 49.0) | 48.8 (48.7 to 48.9) | 56.1 (55.0 to 57.2) | <0.001 |
| Female | 51.1 (51.0 to 51.2) | 51.2 (51.1 to 51.3) | 43.9 (42.8 to 45.0) | |
| Age (years) | ||||
| 18–35 | 34.7 (34.6 to 34.8) | 34.8 (34.7 to 34.9) | 24.1 (23.2 to 25.1) | <0.001 |
| 36–50 | 33.0 (32.9 to 33.1) | 33.0 (32.9 to 33.1) | 29.2 (28.2 to 30.2) | |
| 51–65 | 23.0 (22.9 to 23.1) | 22.9 (22.8 to 23.0) | 27.6 (26.7 to 28.6) | |
| >66 | 9.3 (9.3 to 9.4) | 9.2 (9.2 to 9.3) | 19.0 (18.2 to 19.9) | |
| Self-reported morbidity | ||||
| Diabetes | 12.7 (12.6 to 12.8) | 12.6 (12.5 to 12.7) | 20.6 (19.8 to 21.5) | <0.001 |
| Obesity | 15.9 (15.9 to 16.0) | 15.9 (15.8 to 16.0) | 18.3 (17.4 to 19.1) | <0.001 |
| Hypertension | 16.1 (16.0 to 16.1) | 16.0 (15.9 to 16.1) | 20.3 (19.5 to 21.2) | <0.001 |
| Cardiovascular disease | 1.4 (1.3 to 1.4) | 1.4 (1.3 to 1.4) | 1.5 (1.3 to 1.8) | 0.183 |
| Chronic kidney disease | 1.0 (1.0 to 1.0) | 1.0 (1.0 to 1.0) | 1.8 (1.6 to 2.2) | <0.001 |
| COPD | 0.9 (0.9 to 0.9) | 0.9 (0.9 to 0.9) | 2.9 (2.6 to 3.3) | <0.001 |
| Asthma | 2.3 (2.3 to 2.4) | 2.3 (2.3 to 2.4) | 2.5 (2.2 to 2.8) | 0.341 |
| Smoking | 7.7 (7.7 to 7.8) | 7.7 (7.7 to 7.8) | 5.6 (5.1 to 6.1) | <0.001 |
| Month of presentation to care | ||||
| March to April 2020 | 1.9 (1.9 to 2.0) | 1.9 (1.9 to 2.0) | 3.7 (3.3 to 4.1) | <0.001 |
| May | 6.1 (6.1 to 6.2) | 6.1 (6.0 to 6.1) | 9.6 (9.0 to 10.3) | |
| June | 10.5 (10.4 to 10.5) | 10.4 (10.4 to 10.5) | 13.8 (13.0 to 14.5) | |
| July | 13.2 (13.1 to 13.2) | 13.1 (13.0 to 13.2) | 19.7 (18.9 to 20.6) | |
| August | 10.9 (10.9 to 11.0) | 10.9 (10.9 to 11.0) | 13.3 (12.6 to 14.0) | |
| September | 8.8 (8.7 to 8.8) | 8.8 (8.7 to 8.8) | 8.1 (7.5 to 8.7) | |
| October | 11.1 (11.0 to 11.2) | 11.2 (11.1 to 11.2) | 6.3 (5.7 to 6.8) | |
| November | 12.3 (12.2 to 12.3) | 12.3 (12.2 to 12.4) | 6.4 (5.9 to 7.0) | |
| December | 10.8 (10.8 to 10.9) | 10.9 (10.8 to 10.9) | 6.6 (6.1 to 7.2) | |
| January | 11.0 (11.0 to 11.1) | 11.0 (11.0 to 11.1) | 9.5 (8.9 to 10.1) | |
| 28 February 2021 | 3.3 (3.3 to 3.4) | 3.3 (3.3 to 3.4) | 3.0 (2.7 to 3.4) | |
| Days from symptom onset to presentation to care | ||||
| 0–3 | 46.6 (46.5 to 46.7) | 46.6 (46.5 to 46.7) | 45.5 (44.4 to 46.6) | 0.293 |
| 4–7 | 40.9 (40.8 to 41.1) | 40.9 (40.8 to 41.0) | 41.9 (40.8 to 42.9) | |
| >8 | 12.5 (12.4 to 12.5) | 12.5 (12.4 to 12.5) | 12.7 (12.0 to 13.4) | |
| Contextual | ||||
| Social deprivation* | ||||
| Low | 33.4 (33.3 to 33.5) | 33.6 (33.5 to 33.7) | 10.3 (9.7 to 11.0) | <0.001 |
| Middle | 33.4 (33.3 to 33.5) | 33.6 (33.5 to 33.7) | 10.2 (9.5 to 10.9) | |
| High | 33.2 (33.1 to 33.3) | 32.8 (32.7 to 32.9) | 79.5 (78.6 to 80.4) | |
| Human resources and hospital equipment† | ||||
| Low | 23.9 (23.8 to 24.0) | 23.8 (23.7 to 23.9) | 34.9 (33.9 to 36.0) | <0.001 |
| Middle | 32.3 (32.2 to 32.4) | 32.2 (32.1 to 32.3) | 36.5 (35.4 to 37.5) | |
| High | 43.8 (43.7 to 44.0) | 44.0 (43.9 to 44.1) | 28.6 (27.6 to 29.6) | |
*At municipality level.
†At health jurisdiction level.
COPD, chronic obstructive pulmonary disease; MoH, Ministry of Health.